NRG1 fusion
Showing 1 - 25 of 4,015
Metastatic Pancreatic Cancer Trial in Ottawa (Seribantumab)
Completed
- Metastatic Pancreatic Cancer
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Dec 22, 2021
NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,
Recruiting
- NSCLC Harboring NRG1 Fusion
- Metastatic Castration-resistant Prostate Cancer
- Afatinib Oral Tablet
- +3 more
-
Whittier, California
- +1 more
Dec 20, 2022
NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +3 more
- HMBD-001
- +3 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 16, 2023
NRG1-fused NSCLC Trial in Shanghai (Afatinib Dimaleate)
Not yet recruiting
- NRG1-fused Non-small Cell Lung Cancer
- Afatinib Dimaleate
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Mar 30, 2021
NSCLC, Stage IV, NSCLC Stage IIIB, NSCLC, Stage IIIC Trial in Canada, Hong Kong, United States (tarloxotinib bromide)
Terminated
- NSCLC, Stage IV
- +7 more
- tarloxotinib bromide
-
Irvine, California
- +13 more
Nov 11, 2021
Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)
Not yet recruiting
- Fibrolamellar Hepatocellular Carcinoma
-
Tuebingen, Baden-Würtemberg, GermanyUniversity Hospital Tuebingen
Jun 29, 2023
Spine Fusion, Anesthesia, Local Trial (Liposomal bupivacaine, Bupivacaine)
Not yet recruiting
- Spine Fusion
- Anesthesia, Local
- Liposomal bupivacaine
- Bupivacaine
- (no location specified)
Oct 25, 2023
Spine Fusion, Lumbar Spondylolisthesis, Lumbar Stenosis Trial in Minneapolis (Titanium Fusion Device, PEEK Fusion Device)
Not yet recruiting
- Spine Fusion
- +2 more
- Titanium Fusion Device
- PEEK Fusion Device
-
Minneapolis, MinnesotaTwin Cities Spine Center
Jan 18, 2023
Afatinib Following Immunotherapy in Treatment of Metastatic,
Completed
- Non-squamous, Non-Small Cell Lung Cancer
- Afatinib
- other systemic therapy
-
Dublin, OhioCardinal Health
Jan 18, 2022
Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)
Recruiting
- Protein Kinase Inhibitors
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Nov 9, 2023
Selecting the SSV-1 as LIV in Scheuermann's Kyphosis
Completed
- Scheuermann's Kyphosis
- Select the vertebra above sagittal stable vertebra as the distal fusion level
-
Nanjing, Jiang Su, ChinaDrum Tower Hospital of Nanjing University Medical School
Jul 18, 2023
Spondylosis, Spondylolisthesis, Degenerative Disc Disease Trial in Bern (ViviGen®, rhBMP-2)
Recruiting
- Spondylosis
- +2 more
- ViviGen®
- rhBMP-2
-
Bern, SwitzerlandOrthopädie Sonnenhof
Oct 27, 2022
Intervertebral Disc Disease Trial (Stryker Tritanium Spinal System)
Completed
- Intervertebral Disc Disease
- Stryker Tritanium Spinal System
- (no location specified)
Aug 15, 2022
Post Operative Pain Trial in Cairo (procedure, drug, other)
Recruiting
- Post Operative Pain
- Ultrasound Guided Erector Spinae Plane Block
- +2 more
-
Cairo, EgyptAin-Shams University Hospitals
Feb 1, 2023
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)
Not yet recruiting
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
- (no location specified)
May 28, 2023
Lumbar Fusion With The Icotec CF/PEEK Pedicle System In
Completed
- Degeneration of Lumbar Intervertebral Disc
- Degenerative Spondylolisthesis
- 1- or 2-level spinal fusion
-
Kiel, Schleswig-Holstein, Germany
- +5 more
Dec 1, 2022
Anterior vs Posterior Surgery for Lumbar Isthmic
Recruiting
- Isthmic Spondylolisthesis
- Interbody fusion surgery
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Jan 30, 2023
Health Volunteer Trial in Beijing (Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg, Recombinant human CTLA-4-FC
Recruiting
- Health Volunteer
- Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg
- +9 more
-
Beijing, ChinaPeking University People's Hospital
Feb 15, 2022
NRG - Part 1: Validation of Methods for Estimating Resting
Not yet recruiting
- Sedentary
- +2 more
-
Medellín, Antioquia, Colombia
- +1 more
Apr 15, 2023
Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
Recruiting
- Thyroid Cancer
- NTRK fusion assessment
-
Roma, ItalyRegina Elena National Cancer Institute
Mar 31, 2023
Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)
Terminated
- Clear Cell Sarcoma
- AMG 337
-
El Segundo, California
- +1 more
Dec 9, 2022
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022
COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))
Completed
- COVID-19
- hAd5-S-Fusion+N-ETSD
- Placebo (0.9% (w/v) saline)
-
Newport Beach, CaliforniaHoag Memorial Hospital Presbyterian
Sep 1, 2023